A detailed history of Winton Group LTD transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Winton Group LTD holds 18,945 shares of ORGO stock, worth $73,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,945
Previous 61,066 68.98%
Holding current value
$73,127
Previous $170,000 68.24%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.42 - $3.24 $101,932 - $136,472
-42,121 Reduced 68.98%
18,945 $54,000
Q2 2024

Aug 09, 2024

SELL
$2.28 - $3.03 $9,436 - $12,541
-4,139 Reduced 6.35%
61,066 $170,000
Q1 2024

May 14, 2024

BUY
$2.61 - $4.49 $94,620 - $162,775
36,253 Added 125.22%
65,205 $185,000
Q4 2023

Feb 12, 2024

BUY
$1.97 - $4.21 $18,131 - $38,748
9,204 Added 46.61%
28,952 $118,000
Q3 2023

Nov 13, 2023

BUY
$2.34 - $4.43 $46,210 - $87,483
19,748 New
19,748 $62,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $505M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.